Wyatt Christopher F. 4

What Happened

• Christopher F. Wyatt, Senior Vice President & Controller of HCA Healthcare, exercised stock appreciation rights (SARs) on Feb 5, 2026. The filing shows 10,670 shares acquired at a reported per-share amount of $139.06 (total $1,483,770). To satisfy tax withholding, 5,674 shares were surrendered/disposed at a reported per-share value of $513.76 (total $2,915,074). The related derivative position (the SARs) was reported as converted/disposed at $0.00.

Key Details

• Transaction date: 2026-02-05; Form 4 filed: 2026-02-09 (filed within the required reporting window).
• Acquired: 10,670 shares @ $139.06 (total reported value $1,483,770).
• Withheld/Disposed for taxes: 5,674 shares @ $513.76 (total reported value $2,915,074).
• Derivative/Instrument: SARs converted/exercised (reported disposed at $0.00).
• Footnote: F1 — The stock appreciation rights vested in four equal annual installments beginning Jan 30, 2020.
• Shares owned after the transaction: not specified in the filing.

Context

• This was an exercise of SARs with shares withheld to satisfy tax obligations (a cashless-style settlement), not an open-market purchase or sale for investment. Such exercises are routine for executives when equity awards vest and do not necessarily signal a buy/sell decision by the insider.